Advertisements

Calcimed (VITAMINS)

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Calcimed (VITAMINS)

Property Description
Active ingredient Sodium Ascorbate (INN)
Form Oral Tablet or Powder; Injectable Solution
Pharmacological class Vitamin C Preparation; Antioxidant
Common purpose Essential nutrient supply and tissue support
Origin Synthetic Mineral Salt (derived from Ascorbic Acid)

The Identity and Pharmacological Classification of Calcimed (VITAMINS)

Calcimed (VITAMINS) is fundamentally an Essential Nutrient Supplement that supplies the body with the active form of Vitamin C. Its active ingredient is Sodium Ascorbate (the INN), a mineral salt derivative of Ascorbic Acid. This preparation is broadly classified within the pharmacological group of Antioxidants and is a single-ingredient formulation. It is commonly available in oral forms like tablets or powders, though the substance is also available as an aqueous solution for parenteral (injection) administration. The product is clinically recognized for its role in supporting the body's essential functions, establishing its place in supplementation.


Composition: Sodium Ascorbate vs. Standard Vitamin C

The active component in this product is Sodium Ascorbate (C6H7NaO6), a synthetic mineral salt resulting from the neutralization of L-Ascorbic Acid with sodium. This composition is critical because it is a buffered formulation, which is characterized by a near-neutral physiological pH, unlike pure, acidic Ascorbic Acid. This key differentiating feature allows the substance to deliver the biologically active L-Ascorbate ion to the body in a form that is typically associated with better gastrointestinal tolerance, making it suitable for consistent daily vitamin intake.


What is the General Purpose of Calcimed (VITAMINS)?

The general purpose of Calcimed (VITAMINS) is to ensure the body has sufficient quantities of the essential nutrient Vitamin C to sustain critical functions. The compound primarily functions as a crucial cofactor for enzymes required for the biosynthesis of collagen, the structural protein vital for maintaining the integrity of connective tissues such as blood vessels, skin, and cartilage. The substance also operates as a potent antioxidant, helping to neutralize free radicals and thereby protect cells from oxidative stress. Its core activity involves protecting cells and supporting tissue formation, contributing to general well-being.

Advertisements

What side effects are possible with Calcimed (VITAMINS)?

Possible side effects and safety information

This section describes the officially documented adverse reactions and safety constraints for Calcimed (VITAMINS) based strictly on government regulatory documents, such as FDA Prescribing Information and international Summary of Product Characteristics (SmPC).

Adverse Reaction Scope

The most commonly documented adverse reactions, generally associated with higher doses, relate to Gastrointestinal Disorders. These may include nausea, heartburn, upset stomach, and diarrhea. Other officially classified reactions are associated with the Nervous System (e.g., headache, fatigue) and, for parenteral administration, pain and swelling at the infusion site.

Serious Adverse Reactions and Risk Factors

The regulatory profile highlights several serious risks, which are often contingent on patient factors or prolonged exposure patterns:

  • Renal/Urinary Disorders: The risk of oxalate nephropathy (kidney damage) and nephrolithiasis (kidney stone formation) is documented, particularly with the prolonged use of high doses of the substance. This risk is compounded in patients with pre-existing renal impairment or a history of kidney stones.
  • Blood/Lymphatic System Disorders: The label includes a warning regarding the potential for severe hemolysis (red blood cell destruction) in individuals with Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency.

Specific population-related safety notes exist, including advice regarding the increased risk of oxalate nephropathy in geriatric and certain pediatric patients (under 2 years old), and documented risks for newborns if high doses are administered during pregnancy. Furthermore, the substance is documented to interfere with numerous laboratory tests based on oxidation-reduction reactions (e.g., blood glucose, bilirubin assays), requiring a delay in testing after administration.

Advertisements

Overdose and Emergency Response

Overdose Map: Overdose and when to seek help — official regulatory information for Calcimed (VITAMINS)

Overdose scope

Feature Official Regulatory Statement
Documented Overdose Presentations The classic toxicity state is hypercalcemia (serum calcium levels ge 10.5 mg/dL) or hypercalciuria. Symptoms may include anorexia, weight loss, polyuria, fatigue, and heart arrhythmias. Severe cases may lead to the milk-alkali syndrome (MAS) and renal failure or nephrolithiasis (kidney stones).
Physiological Systems Affected Renal (kidneys), cardiovascular (heart), gastrointestinal, and musculoskeletal systems are affected. Specific mentions include nephrocalcinosis, renal insufficiency, and soft tissue calcifications.
Dose-related or Exposure Factors Overdose is generally associated with excess intake of calcium or Vitamin D supplements. Young children are an at-risk population for Vitamin D overdose from high-concentration supplements, dosage errors, or combined product use.
When Immediate Medical Help is Required If an overdose is suspected, call your local emergency number (such as 911) or Poison Help hotline (1-800-222-1222) immediately and seek medical help right away.

Resulting Overdose Structure

Official Overdose Statements:

  • Overdose of Calcimed (Calcium/Vitamin D component) can lead to the toxicity state of hypercalcemia and may affect the heart and kidneys.
  • Immediate medical help is required, and users must contact emergency services or poison control.
  • Treatment for overdose may include intravenous fluids and certain medications to lower calcium levels, as defined in official documents.

Connection to the overall overdose profile: Regulatory documents define the overdose profile primarily by the resulting condition of hypercalcemia, which can manifest with serious symptoms such as heart arrhythmias and kidney complications. The official guidance emphasizes that this toxicity, particularly when associated with excess supplement intake, requires immediate emergency intervention by calling a poison control center or emergency services.

Advertisements

Therapeutic Uses of Calcimed (VITAMINS)

What Calcimed (VITAMINS) Treats: Main Uses and Benefits

The primary therapeutic role of this medication involves situations requiring additional support for symptom management. This medication is relevant in contexts involving heightened systemic burden, often used in situations involving certain distressing symptoms.

The medication is commonly used across domains where short-term symptomatic assistance is needed. These domains include addressing symptoms associated with temporary functional strain, discomfort related to episodic manifestations, and clusters of symptoms that may intensify temporarily.


Clinical Use and Symptom Relief

Calcimed is applied in clinical settings marked by symptomatic discomfort and is helpful in situations requiring temporary assistance for symptoms that interfere with daily functioning. The medication helps address symptom clusters that may become intense or disruptive and may assist with day-to-day comfort during symptomatic periods. It is often used during phases when symptoms become more noticeable, providing support that helps ease the overall symptom burden. It is relevant in situations where symptoms escalate temporarily.


Quick Fact: Relief for Functional Strain

This medication provides supportive relief when symptoms interfere with routine activities, and assists with functional stability during episodes of heightened discomfort.

Regulatory References

  1. NIH MedlinePlus overview on Vitamin D
Advertisements

Eligibility and Restrictions for Use

Official Eligibility Rules for Calcimed (VITAMINS)

Eligibility to use Calcimed (VITAMINS) (Sodium Ascorbate) is determined by official regulatory documents, primarily based on pre-existing health conditions and the administered dose. The medicine is generally permitted for adults, adolescents, and children at standard nutritional doses, but use is subject to specific restrictions and formal prohibitions.


Absolute Contraindications

Use is contraindicated (must not be used) in patients with known hypersensitivity to Sodium Ascorbate or any excipients. High-dose preparations are also contraindicated for patients with Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency due to the risk of severe hemolysis.

Populations Requiring Restricted Use

Eligibility shifts to restricted or not recommended status when high doses are involved. Use is restricted in patients with a history of oxalate kidney stones or severe renal impairment due to the risk of oxalate buildup. High-dose use is also not recommended for pregnant women, nor is it recommended for patients with conditions that cause iron accumulation (e.g., hemochromatosis).

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section describes the officially documented interaction patterns for Sodium Ascorbate (Calcimed/Vitamin C) as stated in government regulatory sources. These interactions are primarily based on the substance’s chemical properties, which can affect the absorption and clearance of co-administered products.

Exposure-Altering and Pharmacodynamic Interactions

Interacting Substance Officially Documented Interaction Pattern
Iron Salts Significantly enhances the gastrointestinal absorption of non-heme iron, resulting in increased systemic iron exposure.
Aluminum-Containing Antacids Increases the systemic absorption of aluminum, which is a particular concern in patients with reduced renal clearance.
Oral Anticoagulants (e.g., Warfarin) High doses (typically 1 g or more per day) have been noted to potentially reduce the anticoagulant effect.
Fluphenazine, Indinavir May reduce the plasma concentration of these agents, which may require consideration for separated administration.

Interaction-Related Restrictions and Contraindications

Co-administration with Deferoxamine (Desferrioxamine) is formally contraindicated in patients with iron overload and pre-existing cardiac impairment, due to the risk of aggravating cardiac dysfunction. Furthermore, high doses of Vitamin C exceeding 2 grams per day are documented to interfere with laboratory tests, potentially causing false-negative results for fecal occult blood tests.

Advertisements

Mechanism of Action

The mechanism of action for Calcimed (VITAMINS) is defined by the function of the L-Ascorbate ion as a crucial reducing agent and cofactor for defined metalloenzymes, contributing to the regulation of protein structure and cellular redox state.

Enzyme Cofactor Action and Structural Synthesis

This domain involves L-Ascorbate's function in maintaining the active state ( Fe^2+) of enzymes, specifically prolyl and lysyl hydroxylases. This action is indispensable for the correct hydroxylation of procollagen, a key molecular step that results in the formation of the stable, functional collagen triple helix structure, a necessary component of connective tissues like blood vessel walls and bone matrix.


Cellular Redox Regulation

L-Ascorbate acts as a primary, water-soluble antioxidant, directly engaging in redox homeostasis by donating electrons to neutralize harmful Reactive Oxygen Species (ROS). By scavenging these free radicals, the mechanism results in the reduction of cellular macromolecules (DNA, lipids, proteins) from oxidation, thereby sustaining the cellular redox state.


Biosynthesis of Key Signaling Molecules

Beyond structural support, L-Ascorbate is a necessary cofactor for Dopamine beta-hydroxylase, the enzyme that catalyzes the final conversion of dopamine to norepinephrine. This enzymatic support is essential for the body's proper catecholamine synthesis pathway, linking the mechanism to neurohormonal and systemic regulatory functions.

Advertisements

Dosage and Administration Information

How to Use Calcimed (VITAMINS): Administration Guidelines

Calcimed, which contains Sodium Ascorbate, is administered according to a structured protocol, distinguishing between maintenance and therapeutic use.

Administration and Dosage Principles

Administration may be achieved through the oral route (tablet, capsule, or powder) for routine supplementation, or via parenteral routes, specifically intravenous (IV), intramuscular (IM), or subcutaneous (SC) injection, typically when oral intake is difficult or high doses are required.

The required dose is determined by the treatment goal. Nutritional maintenance is generally supported by an oral dose ranging from 50 mg to 500 mg taken once daily. For curative treatment of deficiency, regimens commonly prescribe 500 mg up to 1 gram (1000 mg) daily, often in divided doses.

Procedural and Time Constraints

Oral forms may be taken with or without food. Conversely, the injectable solution must be diluted prior to IV administration and must be delivered as a slow intravenous infusion; the concentrate should not be administered undiluted.

Treatment duration varies: curative courses are generally administered for a minimum of two weeks or until symptoms resolve. Specific, high-dose IV regimens may be subject to a maximum duration of seven days. If an oral dose is missed, it should be skipped and the next scheduled dose should be taken, as double doses are not recommended.

Regarding specific populations, while the pediatric curative dose is numerically lower than the adult dose, older adults typically do not require a special dosage adjustment for the treatment of established deficiency.

Administration Pattern General Instruction
Oral Timing May be taken with or without food
IV Requirement Must be diluted and infused slowly
Curative Duration Minimum of two weeks
Advertisements

Recent Clinical Evidence

Calcimed (VITAMINS): Recent Clinical Evidence

Clinical research on combined calcium and vitamin D supplementation primarily focuses on skeletal health and fracture risk, particularly in older adults and postmenopausal women. The evidence regarding the long-term effects remains mixed across various large-scale trials, highlighting the complexity of nutrient supplementation.

Skeletal Health and Fracture Risk

Multiple randomized controlled trials (RCTs) have explored the association between Calcimed components and bone outcomes. A major network meta-analysis suggested that the combination of calcium and vitamin D was associated with a relative risk reduction for hip fractures when compared to placebo. However, studies often show inconsistent results, with some large trials reporting no significant difference in overall fracture rates, while others observe a protective association only among participants with poor baseline nutrient intake or high compliance with the study regimen.

Cardiovascular and Other Health Outcomes

Research has also investigated effects beyond bone health, producing varied findings:

  • Cardiovascular Events: Long-term follow-up from the Women’s Health Initiative (WHI) trial found that assignment to the calcium and vitamin D group was associated with a small increased risk of cardiovascular disease mortality after more than 20 years of cumulative follow-up. Other meta-analyses examining calcium alone or in combination with vitamin D have not consistently reported an increased risk for major coronary events.
  • Cancer Risk: The same long-term WHI data observed that the combination supplement group had a lower risk of cancer mortality compared to the placebo group. Earlier intervention-period findings generally showed no significant effect on overall cancer incidence.

Overall, the benefits of supplementation are often most apparent in individuals who have an inadequate baseline intake of calcium and vitamin D.

Key Studies & References

  1. Calcium plus Vitamin D Supplementation and the Risk of Fractures: A Meta-analysis of Randomized Controlled Trials
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Calcimed (VITAMINS) (FAQ)


Q: Why does Calcimed combine both calcium and a vitamin in its formulation?

Official product information confirms the active ingredient in Calcimed is Sodium Ascorbate, a single compound that is a synthetic mineral salt derivative of Ascorbic Acid (Vitamin C).

The composition provides Vitamin C in a form that is often associated with better gastrointestinal tolerance. This formulation does not include supplemental calcium, clarifying the identity confusion suggested by the trade name.


Q: Is Calcimed the same as a standard calcium or vitamin D supplement available over the counter?

No, official documentation indicates that Calcimed is classified as a Vitamin C Preparation that supplies the essential nutrient Sodium Ascorbate.

This makes the substance chemically and therapeutically distinct from standard calcium or Vitamin D supplements available for over-the-counter purchase.


Q: How long do temporary side effects from Calcimed typically last?

Official regulatory overviews state that most reported temporary side effects are typically self-limiting, often involving the gastrointestinal system.

These effects are usually described as resolving when use of the medicine is discontinued.


Q: Are there any specific foods or beverages that official labeling describes as potentially interacting with Calcimed?

Regulatory and clinical information indicates no specific interactions with common food items have been formally reported.

Furthermore, the official administration guidelines confirm that oral forms of the medication may be taken with or without food.


Q: Is there any official information about Calcimed interacting with alcohol?

According to reviews of drug interaction databases, no interactions have been formally reported or found between the active substance and alcohol.


Q: What conditions, other than the main ones, is Calcimed sometimes used to support, according to official information?

Official documents describe the substance as being used to manage and prevent Vitamin C deficiency (scurvy).

It also supports essential biological processes like collagen formation for tissue repair and acts as a general antioxidant.


Q: Does official guidance address the use of Calcimed during pregnancy or breastfeeding?

Official guidance recommends that caution be exercised when administering the substance to nursing women, as the substance is known to be excreted into human breast milk.

Separately, there are restrictions on high-dose use during pregnancy.


Q: Are there any known age limits (upper or lower) for the use of Calcimed?

The drug is generally permitted for adults and children at standard nutritional doses. However, official safety documentation notes that high-dose use is associated with an increased risk of oxalate nephropathy (a form of kidney damage) in certain pediatric patients (under 2 years old).


Q: How long after starting Calcimed might a person typically expect to see changes in relevant lab results?

Regulatory documents citing clinical evidence indicate that the reversal of scurvy symptoms, which is one key measure of therapeutic effect, may be observed within two days to three weeks of starting therapy.


Q: Is the term 'contraindication' on the Calcimed label the same as a side effect?

No, these terms describe different safety aspects. A contraindication is a specific situation where a medicine must not be used because it carries a risk of harm.

A side effect is an officially documented unwanted or adverse reaction that can potentially occur during use.


Q: What is the official information regarding the potential for Calcimed to cause constipation?

Official regulatory documents detailing the known adverse reactions do not list constipation among the most commonly documented gastrointestinal effects.

Instead, GI issues like diarrhea and stomach upset are more frequently noted in the safety information.


Q: What is the official description of what happens if a person accidentally takes too much Calcimed?

Excessive intake may lead to acute symptoms such as diarrhea, nausea, and abdominal cramps, and may also increase the long-term risk of kidney stone formation.

Official guidance states that use should be stopped and medical attention should be sought for symptoms that are persistent or severe.


Q: Is Calcimed approved by a major regulatory body like the FDA or EMA?

The active substance, Sodium Ascorbate, has an official monograph and labeling defined by regulatory bodies like the FDA in the United States.

It is also included in the Summary of Product Characteristics (SmPC) used by the EMA in Europe.


Q: What does the package term 'prophylactic use' mean in simple language?

Prophylactic use generally refers to administering a drug or substance to prevent a disease or deficiency from occurring.

This is distinct from using it to treat an existing or active condition.

Advertisements

How should Calcimed (VITAMINS) be stored and disposed of?

The official storage and disposal requirements for Calcimed (Sodium Ascorbate, Vitamin C) are strictly defined by regulatory documents to maintain product integrity and safety.

Labeled Storage Conditions

Storage Component Requirement (Official Labeling)
Temperature Controlled Room Temperature (20 C to 25 C)
Protection Keep in a cool, dry place; Protect from light.
Container Rule Keep the container tightly closed; must have a child-resistant closure.
Prohibition Do not freeze the product.

Handling and Disposal

All medications must be stored out of the reach of children as a mandatory safety requirement. The product should not be used if the bottle seal is broken.

Disposal of any expired or unused Calcimed must be handled according to local regulations for pharmaceutical waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Calcimed (VITAMINS) found in:

A-Z Index: